Home
Top Stories
Markets
Market Data
Companies
Opinion
Economy & Policy
Finance
Politics
Technology
Personal Finance
Current Affairs
International
Management
Weekend
General News
Latest News
Today's Paper
Videos
Covid-19
Portfolio
Login
Indian Pharma
Best of BS Opinion: A change in direction, healing a weak regulator & more
Indian pharma firms go local seeking to end reliance on China
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
Indian exports show signs of revival, up 16.2% to $6.2 bn in Jan first week
V G Somani: The DCGI chief, a man known by his actions, 'not of words'
It's raining billionaires in India's pharma and health care space
A shot at transparency
Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO
Next Covid-19 vaccine challenge: Crossing the economic and patent barrier
The next online tonic: E-majors, corporate giants eye e-pharmacy business
Next